Prof Graeme Eisenhofer

Graeme Eisenhofer received his PhD in 1983 from the University of Otago, New Zealand, with clinical research on autonomic and neuroendocrine systems. He then moved to the NIH where he carried out basic and clinical studies mapping the pathways of catecholamine metabolism. In 1988 he moved to the Baker Heart Research Institute (Melbourne, Australia), where he worked on sympathetic nervous system function in health and disease. He returned to the NIH in 1991 before taking up a Professorship at the University Hospital in Dresden. Together with Dr. Jacques Lenders, Dr. Eisenhofer developed measurements of plasma metanephrines for laboratory diagnosis of pheochromocytoma. He was also responsible for the first ever synthesis of 18F-fluorodopamine as a positron emission tomographic imaging agent for localizing catecholamine-producing tumors. At Dresden Dr. Eisenhofer heads the Division of Clinical Neurochemistry and is the coordinator of a Clinical Research Unit focusing on adrenal hypertension and disorders of adrenal function.